Trial Profile
A Randomised, Open-label, Three-way Crossover Trial to Investigate the Effect of Rifampicin and Probenecid on Empagliflozin Pharmacokinetics in Healthy Male and Female Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Sep 2014
Price :
$35
*
At a glance
- Drugs Empagliflozin (Primary) ; Probenecid; Rifampicin
- Indications Bacterial infections; Gout; Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 01 Aug 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Jul 2012 New trial record